[HTML][HTML] Liver as a target of human immunodeficiency virus infection

M Ganesan, LY Poluektova… - World journal of …, 2018 - ncbi.nlm.nih.gov
Liver injury is a characteristic feature of human immunodeficiency virus (HIV) infection,
which is the second most common cause of mortality in HIV-infected patients. Now it is …

NASH in HIV

A Cervo, M Shengir, K Patel, G Sebastiani - Current HIV/AIDS Reports, 2020 - Springer
Abstract Purpose of Review Aging-related comorbidities, including liver disease, represent
the main drivers of morbidity and mortality in people with HIV (PWH). Nonalcoholic fatty liver …

Risk factors for fatty liver in the Multicenter AIDS Cohort Study

JC Price, EC Seaberg, R Latanich… - Official journal of the …, 2014 - journals.lww.com
OBJECTIVES: Human immunodeficiency virus (HIV) infection and antiretroviral therapy
(ART) may increase the risk of fatty liver disease. We determined the prevalence of and risk …

Nonalcoholic fatty liver disease diagnosed by transient elastography with controlled attenuation parameter in unselected HIV monoinfected patients

É Vuille-Lessard, B Lebouché, L Lennox, JP Routy… - Aids, 2016 - journals.lww.com
Objective: Nonalcoholic fatty liver disease (NAFLD) is the most common liver disease in
Western countries. HIV-infected persons without viral hepatitis are at increased risk of …

Incidence and risk factors for chronic elevation of alanine aminotransferase levels in HIV-infected persons without hepatitis B or C virus co-infection

H Kovari, B Ledergerber, M Battegay… - Clinical infectious …, 2010 - academic.oup.com
Background. Chronic liver disease in human immunodeficiency virus (HIV)–infected patients
is mostly caused by hepatitis virus co-infection. Other reasons for chronic alanine …

Prevalence and risk factors for significant liver fibrosis among HIV-monoinfected patients

M DallaPiazza, VK Amorosa, R Localio… - BMC infectious …, 2010 - Springer
Background HIV-monoinfected patients may be at risk for significant liver fibrosis, but its
prevalence and determinants in these patients are unknown. Since HIV-monoinfected …

Management of the metabolic effects of HIV and HIV drugs

TT Brown, MJ Glesby - Nature reviews endocrinology, 2012 - nature.com
Morphologic and metabolic abnormalities, including subcutaneous adipose tissue wasting,
central adipose tissue accumulation, dyslipidemia and disorders of glucose metabolism are …

Clinical significance of elevated liver transaminases in HIV-infected patients

J Cai, M Osikowicz, G Sebastiani - Aids, 2019 - journals.lww.com
Elevation of liver transaminases is common in patients infected with the HIV. Although this is
usually an incidental finding during regular work-up, HIV-infected patients with transaminase …

Daily cannabis and reduced risk of steatosis in human immunodeficiency virus and hepatitis C virus‐co‐infected patients (ANRS CO 13‐HEPAVIH)

S Nordmann, A Vilotitch, P Roux, L Esterle… - Journal of Viral …, 2018 - Wiley Online Library
Liver steatosis is common in human immunodeficiency virus (HIV)‐hepatitis C virus (HCV)‐
co‐infected patients. Some recent studies have found that cannabis use is negatively …

Influence of antiretroviral therapy on liver disease

H Kovari, R Weber - Current Opinion in HIV and AIDS, 2011 - journals.lww.com
Current expert guidelines recommend earlier treatment of HIV infection in persons
coinfected with hepatitis B virus and possibly hepatitis C virus. It is unknown whether an …